Dyslipidaemia in children on renal replacement therapy.
Bonthuis, Marjolein; van Stralen, Karlijn J; Jager, Kitty J; Baiko, Sergey; Jahnukainen, Timo; Laube, Guido F; Podracka, Ludmila; Seeman, Tomás; Tyerman, Kay; Ulinski, Tim; Groothoff, Jaap W; Schaefer, Franz; Verrina, Enrico.
Nephrol Dial Transplant
; 29(3): 594-603, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24170813
More hostile dyslipidaemia in chronic kidney disease patients on maintenance haemodialysis than on conservative management.
Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
Vitamin E supplementation improves high-densitiy lipoprotein and endothelial functions in end-stage kidney disease patients undergoing hemodialysisâ©.
Association between dyslipidemia and residual renal function in patients on chronic peritoneal dialysis.
What is the role of lipid measurements in end-stage renal disease?
HMG CoA reductase inhibitors (statins) for dialysis patients.
Association of serum lipids with outcomes in Hispanic hemodialysis patients of the West versus East Coasts of the United States.
The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.
Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.